Related Topics:
Facility ID: 45071MYLNH8814T
Facility Name and Address: NATIONAL RESILIENCE INC. 8814 TRADE PORT DR WEST CHESTER, OH 45071 Parent Company: ASTRAZENECA PHARMACEUTICALS LP Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Dichloromethane Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000075092
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2022 |
Other Barriers to Source Reduction - Product that uses dichloromethane will no longer be produced after 2023. |
||
2021 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - At this time there is no available substitution for dichloromethane that allows for the proper formulation of our pharmaceutical product. |
|
2020 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
|
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The product quality will be impacted by using a different solvent in our process. Formulation of the current product has been unsuccessful to date using other solvents. Other Environmental Practices: Recycling - We are currently pursuing recovery of dechloromethane via processing at Veolia for reuse. |
|
2019 |
Source Reduction:: W89: Other product modifications[-5-14%]
|
Methods to Identify SR Opportunities: T06: Employee recommendation (under a formal company program)
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction. |
W89: Recovery of used dechloromethane via processing at Veolia. Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - The product quality will be impacted by using a different solvent in our process. Formulation of the current product has been unsuccessful to date using other solvents. |
2018 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - No substitute for dichloromethane is available that will not reduce the final quality of our product as expected by the US FDA and other international regulatory agencies. |
|
2017 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies. |
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - A decrease in the amount of dichlormethane used in the production process leads to a reduction in product quality. This decrease leads to issues with particle size during the formulation of the drug produced at our site and the product becomes in no longer acceptable for human use. Barriers to P2: B7 - No known substitutes or alternative technologies. - There is no known substitute that can be used in our commercial production process. Other options were examined during the development of the drug manufactured at our site; however, product quality was significantly deminished. |
|
2016 |
Barriers: B3-Barriers to P2 B3 - Concern that product quality may decline as a result of source reduction.
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies. |
Barriers to P2: B3 - Concern that product quality may decline as a result of source reduction. - A decrease in the amount of dichlormethane used in the production process leads to a reduction in quality. This decrease leads to issues with particle size during the formulation of the drug produced at our site and the product becomes in no longer acceptable for human use. Barriers to P2: B7 - No known substitutes or alternative technologies. - There is no known substitute that can be used in our commercial production process. Other options were examined during the development of the drug manufactured at our site; however, product quality was significantly demolished. |
|
2013 |
Source Reduction:: W39: Other spill or leak prevention
|
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
|
|
2012 |
Source Reduction:: W39: Other spill or leak prevention
|
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
|
W39: Increased frequency of calibration on dichloromethane sensor and alarm systems. |
2011 |
Source Reduction:: W33: Installed overflow alarms or automatic shutoff valves
Source Reduction:: W36: Implemented inspection or monitoring program of potential spill or leak sources |
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s) |
W33: We have overflow alarms and shut-offs on all vessels. W36: We do daily inspections and weekly inspections to detect leaks and spills. Source Reduction - We conduct internal pollution prevention audits. Other Environmental Practices - We are investigating the reclaiming of our solvent waste by a Haz Waste Treatment Facility approved by EPA and Permited by EPA. |
2010 |
Source Reduction:: W33: Installed overflow alarms or automatic shutoff valves
Source Reduction:: W36: Implemented inspection or monitoring program of potential spill or leak sources |
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s) |
|
2009 |
Source Reduction:: W33: Installed overflow alarms or automatic shutoff valves
Source Reduction:: W36: Implemented inspection or monitoring program of potential spill or leak sources |
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s) |
|
2008 |
Source Reduction:: W33: Installed overflow alarms or automatic shutoff valves
Source Reduction:: W36: Implemented inspection or monitoring program of potential spill or leak sources |
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s) |
|
2007 |
Source Reduction:: W33: Installed overflow alarms or automatic shutoff valves
Source Reduction:: W36: Implemented inspection or monitoring program of potential spill or leak sources |
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s) |